These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23040590)

  • 1. Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Furuno T; Kitaoka H; Takata J; Sugiura T; Doi Y
    Am J Cardiol; 2013 Jan; 111(1):106-10. PubMed ID: 23040590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Kitaoka H; Takata J; Doi Y; Sugiura T
    Cardiovasc Ultrasound; 2015 Mar; 13():14. PubMed ID: 25880063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy.
    Choi JO; Kim EY; Lee GY; Lee SC; Park SW; Kim DK; Oh JK; Jeon ES
    Circ J; 2013; 77(2):462-9. PubMed ID: 23095684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction.
    Bhat PK; Ashwath ML; Rosenbaum DS; Costantini O
    Am J Cardiol; 2012 Jul; 110(1):83-7. PubMed ID: 22551737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X; Wu B; Chen Y; Li W; Hu X; Chen J
    Int J Cardiol; 2016 Oct; 221():128-33. PubMed ID: 27400309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?
    Merlo M; Stolfo D; Anzini M; Negri F; Pinamonti B; Barbati G; Ramani F; Lenarda AD; Sinagra G
    J Am Heart Assoc; 2015 Jan; 4(1):e001504. PubMed ID: 25587018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.
    Foerster SR; Canter CE; Cinar A; Sleeper LA; Webber SA; Pahl E; Kantor PF; Alvarez JA; Colan SD; Jefferies JL; Lamour JM; Margossian R; Messere JE; Rusconi PG; Shaddy RE; Towbin JA; Wilkinson JD; Lipshultz SE
    Circ Heart Fail; 2010 Nov; 3(6):689-97. PubMed ID: 20833772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular size as a predictor of outcome in patients of non-ischemic dilated cardiomyopathy with severe left ventricular systolic dysfunction.
    Gupta A; Sharma P; Bahl A
    Int J Cardiol; 2016 Oct; 221():310-3. PubMed ID: 27404697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazards of ventricular pre-excitation to left ventricular systolic function and ventricular wall motion in children: analysis of 25 cases.
    Guo B; Dai C; Li Q; Li W; Han L
    Cardiol Young; 2019 Mar; 29(3):380-388. PubMed ID: 30767835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Reverse Remodeling in Recent Onset Idiopathic Dilated Cardiomyopathy Using Contemporary Echo Techniques.
    Goland S; Fugenfirov I; Volodarsky I; Aronson H; Zilberman L; Shimoni S; George J
    Isr Med Assoc J; 2018 Dec; 20(12):749-753. PubMed ID: 30550004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy.
    Merlo M; Masè M; Vitrella G; Belgrano M; Faganello G; Di Giusto F; Boscutti A; Gobbo M; Gigli M; Altinier A; Lesizza P; Barbati G; Ramani F; De Luca A; Morea G; Cova MA; Stolfo D; Sinagra G
    Am J Cardiol; 2018 Aug; 122(3):490-497. PubMed ID: 29958711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Nov; 31(11):1817-1825. PubMed ID: 26843195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional heterogeneity of systolic dysfunction is associated with ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy and narrow QRS complex.
    Matsumoto K; Tanaka H; Tatsumi K; Kaneko A; Tsuji T; Ryo K; Kawai H; Hirata K
    Echocardiography; 2012 Nov; 29(10):1201-10. PubMed ID: 22862431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
    Li W; Li H; Long Y
    Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.
    Singh TP; Sleeper LA; Lipshultz S; Cinar A; Canter C; Webber SA; Bernstein D; Pahl E; Alvarez JA; Wilkinson JD; Towbin JA; Colan SD
    Circ Heart Fail; 2009 Nov; 2(6):591-8. PubMed ID: 19919984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.